https://medicalxpress.com/news/2023-10-idsa-maternal-rsvpref-vaccine-clinical.html
Maternal vaccination with a bivalent stabilized prefusion F subunit respiratory syncytial virus (RSV) vaccine (RSVpreF) is projected to reduce the clinical and economic burden of RSV lower respiratory tract illness (LRTI) in infants, according to a study pres…
Create an account or login to join the discussion